Trial Profile
Phase 1: Safety of Lactobacillus Reuteri in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Jul 2021
Price :
$35
*
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Acute enterocolitis; Constipation; Gastrointestinal disorders; Type 2 diabetes mellitus
- Focus Adverse reactions
- 25 Mar 2015 New trial record